Publications by authors named "David Manner"

Claim this Profile
U
Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study.
Anja Koester, Derrick R Witcher, Mark Lee, Stephen J Demarest, Scott Potter, David Manner

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
Kristin J Meyers, Brian Dillman, Charles Williams, Jianfei Jiang, Nancy Clifford, David H Manner

J Med Virol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
Kristin J Meyers, Meghan E Jones, Iris A Goetz, Fady T Botros, Jack Knorr, David H Manner

J Med Virol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development.
David H Manner, Chakib Battioui, Stefan Hantel, B Nhi Beasley, Lee-Jen Wei

Am Heart J· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications.
Byron J Hoogwerf, David H Manner, Haoda Fu, Elena Moscarelli, Brenda L Gaydos

Diabetes Care· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian methods for design and analysis of safety trials.
Karen L Price, H Amy Xia, Mani Lakshminarayanan, David Madigan, David Manner

Pharm Stat· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical utility index for selecting an optimal insulin dosing algorithm for LY2605541 in patients with type 2 diabetes pretreated with basal insulin.
David H Manner, Junxiang Luo, Yongming Qu, Scott Berry, Brenda L Gaydos

Diabetes Technol Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Drug Development Programs: Type 2 Diabetes Case Study.
Zoran Antonijevic, Martin Kimber, David Manner, Carl-Fredrik Burman, José Pinheiro

Ther Innov Regul Sci· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian adaptive dose-finding studies with delayed responses.
Haoda Fu, David Manner

J Biopharm Stat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vertebral artery-posteroinferior cerebellar artery aneurysms: clinical and lower cranial nerve outcomes in 52 patients.
Hisham Al-khayat, Haitham Al-Khayat, Joseph Beshay, David Manner, Jonathan White

Neurosurgery· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper basilar artery aneurysms: oculomotor outcomes in 163 cases.
Hisham Al-Khayat, Haitham Al-Khayat, Jonathan White, David Manner, Duke Samson

J Neurosurg· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis